Maxwell Sehested
Keine laufenden Positionen mehr
Karriereverlauf von Maxwell Sehested
Ehemalige bekannte Positionen von Maxwell Sehested
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
| TOPOTARGET A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | - |
| Gründer | 27.05.2010 | - |
Statistik
International
| Dänemark | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 2 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
- Börse
- Insiders
- Maxwell Sehested
- Erfahrung
